Bioprospecting for antibacterial drugs: a multidisciplinary perspective on natural product source material, bioassay selection and avoidable pitfalls

TPT Cushnie, B Cushnie, J Echeverría… - Pharmaceutical …, 2020 - Springer
Bioprospecting is the exploration, extraction and screening of biological material and
sometimes indigenous knowledge to discover and develop new drugs and other products …

FabI (enoyl acyl carrier protein reductase)-A potential broad spectrum therapeutic target and its inhibitors

P Rana, SM Ghouse, R Akunuri, YV Madhavi… - European journal of …, 2020 - Elsevier
Abstract Development of new anti-bacterial agents acting upon underexploited targets and
thus evading known mechanisms of resistance is the need of the hour. The highly conserved …

Antibacterial and Antibiofilm Activity and Mode of Action of Magainin 2 against Drug-Resistant Acinetobacter baumannii

MK Kim, NH Kang, SJ Ko, J Park, E Park… - International Journal of …, 2018 - mdpi.com
Antimicrobial peptides (AMPs) are promising therapeutic agents for treating antibiotic-
resistant bacterial infections. Previous studies showed that magainin 2 (isolated from African …

Promising Acinetobacter baumannii Vaccine Candidates and Drug Targets in Recent Years

YC Tan, C Lahiri - Frontiers in Immunology, 2022 - frontiersin.org
In parallel to the uncontrolled use of antibiotics, the emergence of multidrug-resistant
bacteria, like Acinetobacter baumannii, has posed a severe threat. A. baumannii …

[HTML][HTML] Acinetobacter baumannii: A multidrug-resistant pathogen, has emerged in Saudi Arabia

JA Aldali - Saudi Medical Journal, 2023 - ncbi.nlm.nih.gov
A significant opportunistic pathogen, Acinetobacter baumannii (A. baumannii) has evolved
mechanisms of resistance to a wide variety of antimicrobials, including carbapenems. In this …

Insights into Acinetobacter baumannii fatty acid synthesis 3-oxoacyl-ACP reductases

EM Cross, FG Adams, JK Waters, D Aragão… - Scientific reports, 2021 - nature.com
Treatments for 'superbug'infections are the focus for innovative research, as drug resistance
threatens human health and medical practices globally. In particular, Acinetobacter …

Alternatives for the treatment of infections caused by ESKAPE pathogens.

TF Rosa, SS Coelho, VS Foletto… - Journal of Clinical …, 2020 - search.ebscohost.com
What is known and Objective: The widespread use of antibiotics as therapeutic agents
caused an increase of multidrug resistant bacteria (MDR) appearance. Regarding MDRs …

A whole-cell screen identifies small bioactives that synergize with polymyxin and exhibit antimicrobial activities against multidrug-resistant bacteria

SM Zimmerman, AAJ Lafontaine… - Antimicrobial Agents …, 2020 - Am Soc Microbiol
The threat of diminished antibiotic discovery has global health care in crisis. In the United
States, it is estimated each year that over 2 million bacterial infections are resistant to first …

Classification of Staphylococcus aureus FabI inhibitors by machine learning techniques

VG Maltarollo - … on Machine Learning Techniques, Methods, and …, 2022 - igi-global.com
Enoyl-acyl carrier protein reductase (FabI) is a key enzyme in the fatty acid metabolism of
gram-positive bacteria and is considered a potential target for new antibacterial drugs …

Aromatic hydrazides: A potential solution for Acinetobacter baumannii infections

KD Green, NT Chandrika, LY Vu, AH Pang… - European journal of …, 2023 - Elsevier
The emergence of multidrug-resistant bacteria and the poor efficacy of available antibiotics
against these infections have led to the urgent need for novel antibiotics. Acinetobacter …